ATE157701T1 - Schnelle, vielseitige und einfache methode zur expression von genen in eukaryotischen zellen - Google Patents
Schnelle, vielseitige und einfache methode zur expression von genen in eukaryotischen zellenInfo
- Publication number
- ATE157701T1 ATE157701T1 AT90910982T AT90910982T ATE157701T1 AT E157701 T1 ATE157701 T1 AT E157701T1 AT 90910982 T AT90910982 T AT 90910982T AT 90910982 T AT90910982 T AT 90910982T AT E157701 T1 ATE157701 T1 AT E157701T1
- Authority
- AT
- Austria
- Prior art keywords
- versatile
- eukaryotic cells
- fast
- simple method
- expressing genes
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 abstract 1
- 241000700618 Vaccinia virus Species 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32211—Cardiovirus, e.g. encephalomyocarditis virus
- C12N2770/32241—Use of virus, viral particle or viral elements as a vector
- C12N2770/32243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/376,687 US5135855A (en) | 1986-09-03 | 1989-07-07 | Rapid, versatile and simple system for expressing genes in eukaryotic cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE157701T1 true ATE157701T1 (de) | 1997-09-15 |
Family
ID=23486043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90910982T ATE157701T1 (de) | 1989-07-07 | 1990-07-03 | Schnelle, vielseitige und einfache methode zur expression von genen in eukaryotischen zellen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5135855A (de) |
| EP (1) | EP0484374B1 (de) |
| JP (1) | JP2525289B2 (de) |
| AT (1) | ATE157701T1 (de) |
| AU (1) | AU642657B2 (de) |
| CA (1) | CA2063427C (de) |
| DE (1) | DE69031389T2 (de) |
| ES (1) | ES2109924T3 (de) |
| WO (1) | WO1991000905A1 (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE181108T1 (de) * | 1991-08-26 | 1999-06-15 | Immuno Ag | Direkt molekuläre klonierung eines modifizierten genoms eines chordopocken-virus |
| GB9125896D0 (en) * | 1991-12-05 | 1992-02-05 | Almond Jeffrey W | Bicistronic viruses |
| EP0628083A1 (de) | 1992-02-27 | 1994-12-14 | Microbial Technics Limited | Heterologe genexpression in lactococcus und die entsprechenden expressionsprodukte |
| IL102404A0 (en) * | 1992-07-03 | 1993-01-14 | Daniel Zurr | Method and means for the production of gene products |
| US5648235A (en) * | 1992-07-03 | 1997-07-15 | Q.B.I. Enterprises Ltd. | Method and means for the production of gene products, novel recombinant DNA vectors therefor and kits employing them |
| US5409823A (en) * | 1992-09-24 | 1995-04-25 | Ciba-Geigy Corporation | Methods for the production of hybrid seed |
| CN1120315A (zh) * | 1993-04-09 | 1996-04-10 | 维吉尼亚大学专利基金会 | 溶组织内阿米巴粘附外源凝集素的35/31千道尔顿亚基 |
| US5591601A (en) * | 1993-05-14 | 1997-01-07 | Ohio University Edison Animal Biotechnology Institute | DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system |
| WO1995033835A1 (en) | 1994-06-02 | 1995-12-14 | Chiron Corporation | Nucleic acid immunization using a virus-based infection/transfection system |
| US5837464A (en) * | 1996-01-29 | 1998-11-17 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| US6242187B1 (en) * | 1996-01-29 | 2001-06-05 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| US5994526A (en) * | 1996-06-21 | 1999-11-30 | Plant Genetic Systems | Gene expression in plants |
| JP2000513217A (ja) * | 1996-06-21 | 2000-10-10 | プラント・ジェネティック・システムズ・エヌ・ブイ | 植物内での遺伝子発現 |
| CA2264482A1 (en) * | 1996-09-06 | 1998-03-12 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US20020034732A1 (en) * | 1997-07-30 | 2002-03-21 | Daniel J. Capon | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| JP2001519162A (ja) * | 1997-10-07 | 2001-10-23 | ユニバーシティ・オブ・メリーランド・バイオテクノロジー・インスティチュート | 動物細胞にｒｎａを導入して発現させる方法 |
| US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| AU2221600A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
| US7575860B2 (en) * | 2000-03-07 | 2009-08-18 | Evans David H | DNA joining method |
| US20020012971A1 (en) * | 2000-03-20 | 2002-01-31 | Mehta Tammy Burd | PCR compatible nucleic acid sieving medium |
| GB2362383B (en) * | 2000-05-19 | 2003-12-31 | Devgen Nv | Gene expression system |
| AU2002305914A1 (en) | 2001-01-12 | 2002-10-21 | Chiron Corporation | Nucleic acid mucosal immunization |
| AU2002320314A1 (en) | 2001-07-05 | 2003-01-21 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| EP1409694A4 (de) | 2001-07-05 | 2006-02-08 | Chiron Corp | Antigene typ-b- und/oder typ-c-hiv-polypeptide codierende polynukleotide, polypeptide und deren verwendungen |
| WO2006050394A2 (en) | 2004-11-01 | 2006-05-11 | Novartis Vaccines And Diagnostics Inc. | Combination approaches for generating immune responses |
| WO2007081447A2 (en) | 2005-11-22 | 2007-07-19 | Novartis Vaccines And Diagnostics, Inc. | Norovirus and sapovirus antigens |
| DE102006015321A1 (de) * | 2006-03-30 | 2007-10-04 | Rina-Netzwerk Rna Technologien Gmbh | Verfahren zur Genexpression |
| CA2748788C (en) * | 2009-01-05 | 2021-02-09 | Epitogenesis Inc. | The use of a composition comprising mustard oil, catechin, and vitamin a for modulating an immune response |
| EP2723378A4 (de) | 2011-06-24 | 2015-01-28 | Epitogenesis Inc | Pharmazeutische zusammensetzungen mit einer kombination aus ausgewählten trägern, vitaminen, tanninen und flavonoiden als antigenspezifischen immunmodulatoren |
| WO2015073707A1 (en) | 2013-11-15 | 2015-05-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating heart failure with agonists of hypocretin receptor 2 |
| US10550379B2 (en) | 2015-06-29 | 2020-02-04 | The Board Of Trustees Of The Leland Stanford Junior University | Degron fusion constructs and methods for controlling protein production |
| CN108348593B (zh) | 2015-08-31 | 2022-08-16 | 泰克诺瓦克斯股份有限公司 | 基于人呼吸道合胞病毒(hrsv)病毒样颗粒(vlps)的疫苗 |
| WO2017222911A1 (en) | 2016-06-20 | 2017-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Circular rnas and their use in immunomodulation |
| CN111344403B (zh) | 2017-09-15 | 2025-05-06 | 利兰斯坦福初级大学董事会 | 遗传工程细胞的多元性产生和条形码编制 |
| US12239699B2 (en) | 2018-09-11 | 2025-03-04 | Shanghai Public Health Clinical Center | Immunogen for broad-spectrum influenza vaccine and application thereof |
| EP4738279A3 (de) | 2021-02-19 | 2026-05-13 | The Broad Institute Inc. | Multiskalare räumliche transkriptomikanalyse |
| EP4334471A1 (de) | 2021-05-07 | 2024-03-13 | The Broad Institute Inc. | Räumlich-zeitlich aufgelöste transkriptomik bei subzellulärer auflösung |
| US20250011787A1 (en) | 2021-10-21 | 2025-01-09 | The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads | Retroelement-generated transcription factor decoys |
| US20250043269A1 (en) | 2021-11-03 | 2025-02-06 | The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glad | Precise Genome Editing Using Retrons |
| WO2023141602A2 (en) | 2022-01-21 | 2023-07-27 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| US20250215458A1 (en) | 2022-03-25 | 2025-07-03 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David | Production of reverse transcribed DNA (RT-DNA) using a retron reverse transcriptase from exogenous RNA |
| US20250215422A1 (en) | 2022-03-25 | 2025-07-03 | The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads | RT-DNA Fidelity and Retron Genome Editing |
| US20250223586A1 (en) | 2022-03-25 | 2025-07-10 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David | Methods of assessing engineered retron activity, and uses thereof |
| JP2025525569A (ja) | 2022-07-18 | 2025-08-05 | レナゲード セラピューティクス マネージメント インコーポレイテッド | 遺伝子編集成分、システム、及び使用方法 |
| US20250243516A1 (en) | 2022-08-24 | 2025-07-31 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David | Dual Cut Retron Editors for Genomic Insertions and Deletions |
| AU2023329392A1 (en) | 2022-08-25 | 2025-02-27 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| WO2025081042A1 (en) | 2023-10-12 | 2025-04-17 | Renagade Therapeutics Management Inc. | Nickase-retron template-based precision editing system and methods of use |
| WO2025155753A2 (en) | 2024-01-17 | 2025-07-24 | Renagade Therapeutics Management Inc. | Improved gene editing system, guides, and methods |
| WO2025189030A1 (en) | 2024-03-07 | 2025-09-12 | Stellaromics, Inc. | Methods and systems for volumetric imaging |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8613481D0 (en) * | 1986-06-04 | 1986-07-09 | Diatech Ltd | Translation of mrna |
| US4937190A (en) * | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
| AU4507589A (en) * | 1988-10-11 | 1990-05-01 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | New plasmid constructions for high level production of eukaryotic proteins |
-
1989
- 1989-07-07 US US07/376,687 patent/US5135855A/en not_active Expired - Lifetime
-
1990
- 1990-07-03 ES ES90910982T patent/ES2109924T3/es not_active Expired - Lifetime
- 1990-07-03 EP EP90910982A patent/EP0484374B1/de not_active Expired - Lifetime
- 1990-07-03 JP JP2510227A patent/JP2525289B2/ja not_active Expired - Lifetime
- 1990-07-03 AU AU60344/90A patent/AU642657B2/en not_active Expired
- 1990-07-03 CA CA002063427A patent/CA2063427C/en not_active Expired - Lifetime
- 1990-07-03 AT AT90910982T patent/ATE157701T1/de not_active IP Right Cessation
- 1990-07-03 WO PCT/US1990/003687 patent/WO1991000905A1/en not_active Ceased
- 1990-07-03 DE DE69031389T patent/DE69031389T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5135855A (en) | 1992-08-04 |
| EP0484374B1 (de) | 1997-09-03 |
| ES2109924T3 (es) | 1998-02-01 |
| JP2525289B2 (ja) | 1996-08-14 |
| JPH05501048A (ja) | 1993-03-04 |
| DE69031389T2 (de) | 1998-03-19 |
| EP0484374A4 (en) | 1993-05-05 |
| DE69031389D1 (de) | 1997-10-09 |
| AU642657B2 (en) | 1993-10-28 |
| CA2063427C (en) | 1999-09-21 |
| CA2063427A1 (en) | 1991-01-08 |
| WO1991000905A1 (en) | 1991-01-24 |
| AU6034490A (en) | 1991-02-06 |
| EP0484374A1 (de) | 1992-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69031389D1 (de) | Schnelle, vielseitige und einfache methode zur expression von genen in eukaryotischen zellen | |
| DK0561890T3 (da) | DNA ekspressionssystemer baseret på alphavira | |
| DK592186D0 (da) | Fremgangsmaade til udvinding af proteiner | |
| BG101103A (bg) | Теломераза при бозайници | |
| ATE335831T1 (de) | Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis | |
| BR0010725A (pt) | Expressão e exportação de proteìnas de interferon-alfa como proteìnas de fusão de fc | |
| ATE140968T1 (de) | Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert | |
| ATE331034T1 (de) | Samenstrenung resistenz | |
| ATE500323T1 (de) | Subtilisin-variante | |
| DK198883D0 (da) | Fremgangsmade til fremstilling af menneskevaevs-plasminogenaktivator, dna-sekvens der koder for denne aktivator, replicerbar udtrykkelsesvektor for dna-sekvensen og microorganisme eller cellekultur transformeret med udtrykkelsesvektoren | |
| ATE195148T1 (de) | Prozess zur rekombinanten herstellung von hiv-2 - proteinen sowie zellen, die hiv-2 - proteine exprimiert | |
| DE69334211D1 (de) | Multidrug resistenz gen | |
| DE3382068D1 (de) | Verfahren zum einbringen von klonierten amplifizierbaren genen in eukaryotische zellen und zur herstellung von proteinprodukten. | |
| WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
| PT84089B (pt) | Sequencias de adn codificando para proteinas possuindo a actividade biologica dos inibidores de husi-tipo i, processos biotecnologicos para a preparacao das referidas proteinas e de composicoes farmaceuticas contendo as referidas proteinas | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| DE69024447D1 (de) | Induzierer einer tumorlysierenden Zelle, Verfahren und Gerät zur Induzierung tumorlysierender Zellen | |
| EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
| WO2002050111A3 (en) | Isolated laminin 10 | |
| DE69922248D1 (de) | Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen | |
| EP0227604A3 (de) | Verwendung von Oligopeptiden in der Behandlung von viralen Infektionen | |
| Konstantinović et al. | Nuclear matrix from resting and concanavalin A-stimulated human lymphocytes | |
| AR024212A1 (es) | Virus celo recombinante y adn de virus celo. | |
| DE60115039D1 (de) | Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität | |
| WO2002083896A3 (en) | Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |